Evidence map›Paper›PMID 17331988›Full record

ArticleThe Journal of physiology2007

Nitroxyl increases force development in rat cardiac muscle.

Tieying Dai, Ye Tian, Carlo Gabriele Tocchetti, Tatsuo Katori, Anne M Murphy, David A Kass, Nazareno Paolocci, Wei Dong Gao

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Para-SubstitutedMolecules (Basel, Switzerland) · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Anesthetic Agents Isoflurane and Propofol Decrease Maximal CaThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  9. Review
  10. Fropofol decreases force development in cardiac muscle.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  11. Review
  12. Molecular mechanism of anesthetic-induced depression of myocardial contraction.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Nitroxyl (HNO) for treatment of acute heart failure.Current heart failure reports · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Tieying DaiDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Tower 711, 600 N Wolfe Street, Baltimore, MD 21287, USA.
Ye Tian
Carlo Gabriele Tocchetti
Tatsuo Katori
Anne M Murphy
David A Kass
Nazareno Paolocci
Wei Dong Gao
Harbin Medical University · CNJohns Hopkins Medicine · USUniversity of Perugia · IT

Funding

Pathobiology of Cardiac Dyssynchrony &ResynchronizationP01HL077180 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KASS, DAVID ALAN · 2004 to 2014
$22.8M
MOLECULAR PHYSIOLOGY OF MYOCARDIAL TROPONIN I VARIANTSR01HL063038 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MURPHY, ANNE M · 1999 to 2018
$6.2M
CELLULAR MECHANISMS OF CARDIAC CONTRACTILE DYSFUNCTIONR01HL044065 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GAO, WEI · 1990 to 2004
$1.7M
Nitroxyl cardiac effects are mediated by cAMP/PKA signalR01HL075265 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PAOLOCCI, NAZARENO · 2005 to 2008
$1.5M
Molecular Physiology of Myocardial Troponin I VariantsR56HL063038 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MURPHY, ANNE M · 2008 to 2008
$500k
NHLBI NIH HHS HL075265NHLBI NIH HHS HL077180NHLBI NIH HHS HL44065NHLBI NIH HHS HL63038NHLBI NIH HHS P01 HL077180NHLBI NIH HHS R01 HL044065NHLBI NIH HHS R01 HL063038NHLBI NIH HHS R01 HL075265NHLBI NIH HHS R56 HL063038
6 · The paper itself

Abstract

Donors of nitroxyl (HNO), the reduced congener of nitric oxide (NO), exert positive cardiac inotropy/lusitropy in vivo and in vitro, due in part to their enhancement of Ca(2+) cycling into and out of the sarcoplasmic reticulum. Here we tested whether the cardiac action of HNO further involves changes in myofilament-calcium interaction. Intact rat trabeculae from the right ventricle were mounted between a force transducer and a motor arm, superfused with Krebs-Henseleit (K-H) solution (pH 7.4, room temperature) and loaded iontophoretically with fura-2 to determine [Ca(2+)](i). Sarcomere length was set at 2.2-2.3 microm. HNO donated by Angeli's salt (AS; Na(2)N(2)O(3)) dose-dependently increased both twitch force and [Ca(2+)](i) transients (from 50 to 1000 microm). Force increased more than [Ca(2+)](i) transients, especially at higher doses (332 +/- 33% versus 221 +/- 27%, P < 0.01 at 1000 microm). AS/HNO (250 microm) increased developed force without changing Ca(2+) transients at any given [Ca(2+)](o) (0.5-2.0 mm). During steady-state activation, AS/HNO (250 microm) increased maximal Ca(2+)-activated force (F(max), 106.8 +/- 4.3 versus 86.7 +/- 4.2 mN mm(-2), n = 7-8, P < 0.01) without affecting Ca(2+) required for 50% activation (Ca(50), 0.44 +/- 0.04 versus 0.52 +/- 0.04 microm, not significant) or the Hill coefficient (4.75 +/- 0.67 versus 5.02 +/- 1.1, not significant). AS/HNO did not alter myofibrillar Mg-ATPase activity, supporting an effect on the myofilaments themselves. The thiol reducing agent dithiothreitol (DTT, 5.0 mm) both prevented and reversed HNO action, confirming AS/HNO redox sensitivity. Lastly, NO (from DEA/NO) did not mimic AS/HNO cardiac effects. Thus, in addition to reported changes in Ca(2+) cycling, HNO also acts as a cardiac Ca(2+) sensitizer, augmenting maximal force without altering actomyosin ATPase activity. This is likely to be due to modulation of myofilament proteins that harbour reactive thiolate groups that are targets of HNO.

Indexed as

AnimalsCa(2+) Mg(2+)-ATPaseCalciumHeartHydrazinesIntracellular MembranesIn Vitro TechniquesMyocardial ContractionMyocardiumMyofibrilsNitric Oxide DonorsNitritesNitrogen OxidesOsmolar ConcentrationRatsRats, Sprague-Dawley1,1-diethyl-2-hydroxy-2-nitrosohydrazineCa(2+) Mg(2+)-ATPaseCalciumHydrazinesNitric Oxide DonorsNitritesNitrogen Oxidesnitroxyloxyhyponitrite

Identifiers

PMID17331988
PMCPMC2075441
OpenAlexW1538762668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.